Previous studies have shown that serum autoantibodies and IFN-α in SLE patients can regulate the CaMKIV/CREMα signaling pathway, inducing neutrophil ferroptosis by inhibiting GPX4 activity and leading to increased lipid ROS (95). This evidence concerns the gene IFNA1 and systemic lupus erythematosus.